Number of the records: 1
polymyozitída
SYS d017285 LBL 00000nz--a2200000o--4500 005 20250606213310.0 008 920522|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a C05.651.594.819 065 $a C10.668.491.562.575 066 $a 01 $c 03 150 $a polymyozitída $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $2 slo 450 $w v $a Myositis, Multiple $2 eng 450 $w v $a myozitída mnohopočetná $2 slo 665 $a 93 $2 eng 665 $a Myositis (1966-1992) $2 eng 680 9-
$i Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) $2 eng 750 -2
$a Polymyositis $2 eng 980 $x M
Number of the records: 1